Evaxion A (EVAX) Change in Working Capital (2020 - 2022)
Evaxion A (EVAX) posted Change in Working Capital of $427000.0 for Q2 2022, up 119.69% on a QoQ basis from -$2.2 million in Q1 2022, and up 42.33% year-over-year from $300000.0 in Q2 2021.
Evaxion A (EVAX) Change in Working Capital (2020 - 2022) Analysis & Trends
Evaxion A's Change in Working Capital history runs 3 years deep, the most recent figure standing at $427000.0 for Q2 2022.
- Quarterly Change in Working Capital rose 42.33% year-over-year to $427000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was -$2.0 million (down 248.19% YoY) and the FY2024 annual result came in at -$520000.0, up 66.71% from the prior year.
- Change in Working Capital was $427000.0 for Q2 2022 at Evaxion A, up from -$2.2 million in the prior quarter.
- Across five years, Change in Working Capital topped out at $1.0 million in Q1 2021 and bottomed at -$2.2 million in Q1 2022.
- A 3-year average of -$165500.0 and a median of $22000.0 in 2020 frame the typical range for Change in Working Capital.
- Peak annual rise in Change in Working Capital reached 591.8% in 2021, while the deepest fall reached 677.14% in 2021.
- Evaxion A's Change in Working Capital stood at $105000.0 in 2020, then tumbled by 677.14% to -$606000.0 in 2021, then jumped by 170.46% to $427000.0 in 2022.
- Business Quant data shows EVAX's Change in Working Capital at $427000.0 in Q2 2022, -$2.2 million in Q1 2022, and -$606000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 427,000.00 |
| Jun 30, 2022 | 427,000.00 |
| Mar 31, 2022 | -2.17 Mn |
| Mar 31, 2022 | -2.17 Mn |
| Sep 30, 2021 | -606,000.00 |
| Sep 30, 2021 | -606,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 1.04 Mn |
| Mar 31, 2021 | 1.04 Mn |
| Sep 30, 2020 | 105,000.00 |
| Sep 30, 2020 | 105,000.00 |
| Jun 30, 2020 | -61,000.00 |
| Jun 30, 2020 | -61,000.00 |
| Mar 31, 2020 | -358,000.00 |
| Mar 31, 2020 | -358,000.00 |